Dermatology Medical News about Human papillomavirus

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution-associated disease
British Journal of Dermatology, 09/03/09

Bunker CB et al. – Human immunodeficiency virus (HIV)–related cutaneous and anogenital disease in the highly active antiretroviral therapy (HAART) era presents challenging problems for dermatologists. Immune reconstitution–associated diseases (IRADs) are common and important consequences of HAART. Dermatologists should be aware of the cutaneous manifestations of IRAD.

<< Previous
Polyphenon E: a new treatment for external anogenital warts

Next >>
Lupus erythematosus tumidus is a separate subtype of cutaneous...

Human papillomavirus infection in Beijing, People's Republic of China: a population-based study
British Journal of Cancer, 10/01/09 Relevance Score: 68%

Human Papillomavirus (HPV) Type 18 Induces Extended Growth in Primary Human Cervical, Tonsillar, or Foreskin Keratinocytes More Effectively than Other High-Risk Mucosal HPVs
Journal of Virology, 11/09/09 Relevance Score: 66%

Human Papillomavirus (HPV) Type 16 and Type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-Year Follow-Up
The Journal of Infectious Diseases, 10/29/09 Relevance Score: 66%

Human papillomavirus type 16 and 18 in primary lung cancers—a meta-analysis
Carcinogenesis, 10/12/09 Relevance Score: 66%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09 Relevance Score: 66%